DBG
De Burlo Group Portfolio holdings
AUM
$759M
This Quarter Return
+5.04%
1 Year Return
+24.77%
3 Year Return
+146.35%
5 Year Return
+326.03%
10 Year Return
+1,922.48%
AUM
$411M
AUM Growth
+$411M
(+14%)
Cap. Flow
+$62.7M
Cap. Flow
% of AUM
15.26%
Top 10 Holdings %
Top 10 Hldgs %
32.14%
Holding
110
New
12
Increased
21
Reduced
50
Closed
15
Top Buys
| 1 |
Cognex
CGNX
|
$15M |
| 2 |
Citigroup
C
|
$13.8M |
| 3 |
SBNY
Signature Bank
SBNY
|
$11.3M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
$10.6M |
| 5 |
Bank of New York Mellon
BK
|
$10.2M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$6.18M |
| 2 |
Edwards Lifesciences
EW
|
$5.58M |
| 3 |
Crown Castle
CCI
|
$5.43M |
| 4 |
AvalonBay Communities
AVB
|
$5.09M |
| 5 |
Verizon
VZ
|
$3.59M |
Sector Composition
| 1 | Technology | 25.06% |
| 2 | Healthcare | 18.77% |
| 3 | Financials | 18.27% |
| 4 | Communication Services | 9.26% |
| 5 | Consumer Discretionary | 8.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Visa
V
$683B
| $6.82M | 1.66% |
87,400
+12,800
| +17% | +$999K |
|
27
Qualcomm
QCOM
$173B
| $6.5M | 1.58% |
+99,700
| New | +$6.5M |
|
28
Procter & Gamble
PG
$368B
| $5.75M | 1.4% |
68,393
-19,800
| -22% | -$1.66M |
|
29
Church & Dwight Co
CHD
$22.7B
| $5.63M | 1.37% |
127,300
-25,300
| -17% | -$1.12M |
|
|
CMD
30
DELISTED
Cantel Medical Corporation
CMD
| $5.53M | 1.35% |
70,200
+12,400
| +21% | +$976K |
|
31
Schlumberger
SLB
$55B
| $5.26M | 1.28% |
+62,600
| New | +$5.26M |
|
32
Stryker
SYK
$150B
| $5.16M | 1.26% |
43,050
-11,600
| -21% | -$1.39M |
|
33
Aramark
ARMK
$10.3B
| $5.07M | 1.23% |
141,850
-14,750
| -9% | -$527K |
|
34
AbbVie
ABBV
$372B
| $5.05M | 1.23% |
80,650
-41,900
| -34% | -$2.62M |
|
35
Ciena
CIEN
$13.3B
| $4.8M | 1.17% |
196,800
-1,900
| -1% | -$46.4K |
|
36
Atmos Energy
ATO
$26.7B
| $4.69M | 1.14% |
63,300
+1,000
| +2% | +$74.1K |
|
|
BCR
37
DELISTED
CR Bard Inc.
BCR
| $4.52M | 1.1% |
20,100
+4,000
| +25% | +$899K |
|
38
Masco
MAS
$15.4B
| $4.32M | 1.05% |
136,650
-23,250
| -15% | -$735K |
|
39
Henry Schein
HSIC
$8.44B
| $3.85M | 0.94% |
25,370
-15,590
| -38% | -$2.37M |
|
|
40
Thermo Fisher Scientific
TMO
$186B
| $3.7M | 0.9% |
26,250
-43,800
| -63% | -$6.18M |
|
41
Intel
INTC
$107B
| $3.67M | 0.89% |
101,041
-13,700
| -12% | -$497K |
|
42
AT&T
T
$209B
| $3.42M | 0.83% |
80,497
-23,800
| -23% | -$1.01M |
|
43
Gilead Sciences
GILD
$140B
| $3.24M | 0.79% |
45,203
-3,372
| -7% | -$241K |
|
44
Starbucks
SBUX
$100B
| $3.2M | 0.78% |
57,600
-5,900
| -9% | -$328K |
|
|
ALXN
45
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $3.13M | 0.76% |
25,614
-2,070
| -7% | -$253K |
|
46
Oneok
OKE
$48.1B
| $3.07M | 0.75% |
53,450
-3,800
| -7% | -$218K |
|
47
NextEra Energy, Inc.
NEE
$148B
| $3.05M | 0.74% |
25,500
-2,300
| -8% | -$275K |
|
48
Core Laboratories
CLB
$540M
| $3.04M | 0.74% |
+25,300
| New | +$3.04M |
|
|
49
Verizon
VZ
$186B
| $2.98M | 0.73% |
55,850
-67,200
| -55% | -$3.59M |
|
50
Dentsply Sirona
XRAY
$2.85B
| $2.87M | 0.7% |
49,650
-4,900
| -9% | -$283K |
|